Pharmaceutical Formulations and Compositions of a Selective Antagonist of Either CXCR2 or Both CXCR1 and CXCR2 and Methods of Using the Same for Treating Inflammatory Disorders

The present invention provides compositions as well as kits and methods based on a selective antagonist of either CXCR2 or both CXCR1 and CXCR2 that are useful for treating inflammatory disorders.

Saved in:
Bibliographic Details
Main Authors KOU JIM H, EICHMAN JONATHAN D
Format Patent
LanguageEnglish
Published 24.01.2008
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention provides compositions as well as kits and methods based on a selective antagonist of either CXCR2 or both CXCR1 and CXCR2 that are useful for treating inflammatory disorders.
AbstractList The present invention provides compositions as well as kits and methods based on a selective antagonist of either CXCR2 or both CXCR1 and CXCR2 that are useful for treating inflammatory disorders.
Author EICHMAN JONATHAN D
KOU JIM H
Author_xml – fullname: KOU JIM H
– fullname: EICHMAN JONATHAN D
BookMark eNqNj0FuwkAMRbOgC2i5gyXWSJN0wxYCCBZIqAGpO2QlDhlpxo5mTKXeiiMyhB6gK9vP_v_Lk2zEwjTO7scOg8eabmprdLCV4G8O1QpHQG6gFN9LtC8gLSBU5KhW-0OwZMWrsI363GysdhSg_C6_CpAAK9FumPKX0cCf3YG0k2ZwO0fLV0g6qNATtEl2CpTiE91z69B7VAm_sLZRQkMhfmRvLbpI07_6ns22m1O5m1MvF4p9eoVJL-eqMGZhijw3Zpl__u_qAbRiWuM
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2008021100A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2008021100A13
IEDL.DBID EVB
IngestDate Fri Jul 19 16:01:24 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2008021100A13
Notes Application Number: US20070761588
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080124&DB=EPODOC&CC=US&NR=2008021100A1
ParticipantIDs epo_espacenet_US2008021100A1
PublicationCentury 2000
PublicationDate 20080124
PublicationDateYYYYMMDD 2008-01-24
PublicationDate_xml – month: 01
  year: 2008
  text: 20080124
  day: 24
PublicationDecade 2000
PublicationYear 2008
RelatedCompanies SCHERING CORPORATION
RelatedCompanies_xml – name: SCHERING CORPORATION
Score 2.693168
Snippet The present invention provides compositions as well as kits and methods based on a selective antagonist of either CXCR2 or both CXCR1 and CXCR2 that are useful...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Pharmaceutical Formulations and Compositions of a Selective Antagonist of Either CXCR2 or Both CXCR1 and CXCR2 and Methods of Using the Same for Treating Inflammatory Disorders
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080124&DB=EPODOC&locale=&CC=US&NR=2008021100A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8MwMIwp6ptOxY8pB0rfit2WLvShyJa2TGEfrJvsbTRrioJrx1rxb_kTvWSr7mlv6R09aK53uct9EfKIFrjNRLQwmbDbJkUJMgWTlmlHbTtmIrYd3buzP2j3pvR1Zs8q5LOshdF9Qr91c0SUqAXKe6H19er_EsvTuZX5k_hAUPYcTFzPKL1jpW-p4XVdfzT0htzg3J2GxmC8wSlnx-qgr3SAhjRT8uC_dVVdymr3UAlOyeEI6aXFGanItEaOeTl7rUaO-tuQNy630pefk5_R--4FNARob26nb-UQpTEo4S6TsCBLIIJQj7lBjQadVMWfVJ9chfFVKcYa-IyPm5CtoYsM00-NDSENV6u-njCtqensAsD3IIyWEtDahYk2ORH6kib4ay11yB7Kjp75BXkI_Anvmfjp87-dnk_D3X1qXZJqmqXyioBDmzJJLCnR3KOSNUTMaORYDvK2lSwkuyb1fZRu9qNvyckmDaNhNmmdVIv1l7zDs74Q95pFv9UDr3o
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LTsJAcEPQiDdFjQ_USTS9NRZo2fRADPQRUAqEFsONtHQbTWRLaI2_5Sc6u1DlxG07k07Snc7szM6LkEe0wA0ahQuVRkZL1VGC1IgyTTXClhHTKDZM2bvTG7Z6U_1lZsxK5LOohZF9Qr9lc0SUqAXKey719er_EsuWuZXZU_SBoPTZDdq2UnjHQt_qit1tO-ORPbIUy2pPfWU42eCEs6N10Fc6QCObCnlw3rqiLmW1e6i4J-RwjPR4fkpKjFdJxSpmr1XJkbcNeeNyK33ZGfkZv-9eQIOL9uZ2-lYGIY9BCHeRhAVpAiH4cswNajTocBF_En1yBcYRpRhrsGbWpAHpGrrIMPlU3xCScLHy5IRpSU1mFwC-B364ZIDWLgTS5ERonyf4ay1lyB6Kjp7ZOXlwncDqqfjp87-dnk_93X1qXpAyTzm7JGDqDZYkGmNo7umM1qOY6qGpmcjbZrJg9IrU9lG63o--J5Ve4A3mg_7w9YYcb1Iy6mpDr5Fyvv5it3ju59GdZNcvP3-ybQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Pharmaceutical+Formulations+and+Compositions+of+a+Selective+Antagonist+of+Either+CXCR2+or+Both+CXCR1+and+CXCR2+and+Methods+of+Using+the+Same+for+Treating+Inflammatory+Disorders&rft.inventor=KOU+JIM+H&rft.inventor=EICHMAN+JONATHAN+D&rft.date=2008-01-24&rft.externalDBID=A1&rft.externalDocID=US2008021100A1